These T cell populations contribute to AD pathology by producing pro-inflammatory cytokines such as IL-4, IL-13, and IL-17A, which promote barrier dysfunction, keratinocyte activation, and recruitment of additional immune cells 12,13. This evidence concerns the gene IL17A and Alzheimer disease.